{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:27:46Z","timestamp":1786991266157,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lipidjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.jacl.2018.06.017","type":"journal-article","created":{"date-parts":[[2018,7,4]],"date-time":"2018-07-04T07:31:32Z","timestamp":1530689492000},"page":"1190-1198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Efficacy of repeated phlebotomies in hypertriglyceridemia and iron overload: A prospective, randomized, controlled trial"],"prefix":"10.1016","volume":"12","author":[{"given":"Roc\u00edo","family":"Mateo-Gallego","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Lacalle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sof\u00eda","family":"P\u00e9rez-Calahorra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Marco-Bened\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valle","family":"Recasens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noelia","family":"Padr\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9647-0108","authenticated-orcid":false,"given":"Itziar","family":"Lamiquiz-Moneo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00eda","family":"Baila-Rueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Est\u00edbaliz","family":"Jarauta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Calmarza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Cenarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7043-0952","authenticated-orcid":false,"given":"Fernando","family":"Civeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2018.06.017_bib1","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.2337\/diacare.27.10.2422","article-title":"Serum ferritin and risk of the metabolic syndrome in U.S. adults","volume":"27","author":"Jehn","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacl.2018.06.017_bib2","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/sj.ejcn.1602384","article-title":"Metabolic syndrome, insulin resistance and the inflammation markers C-reactive protein and ferritin","volume":"60","author":"Gonz\u00e1lez","year":"2006","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.jacl.2018.06.017_bib3","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1210\/jc.2014-4409","article-title":"Association of ferritin elevation and metabolic syndrome in males. Results from the Aragon Workers' Health Study (AWHS)","volume":"100","author":"Ledesma","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacl.2018.06.017_bib4","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1097\/00004872-200208000-00013","article-title":"Increased serum ferritin is common in men with essential hypertension","volume":"20","author":"Piperno","year":"2002","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacl.2018.06.017_bib5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0021-9150(96)05994-1","article-title":"Relationship of serum ferritin concentrations with metabolic cardiovascular risk factors in men without evidence for coronary artery disease","volume":"128","author":"Halle","year":"1997","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2018.06.017_bib6","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.2337\/diacare.28.8.2061","article-title":"Prevalence of body iron excess in the metabolic syndrome","volume":"28","author":"Bozzini","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacl.2018.06.017_bib7","doi-asserted-by":"crossref","first-page":"426","DOI":"10.2337\/diacare.20.3.426","article-title":"Body iron stores are associated with serum insulin and blood glucose concentrations. Population study in 1,013 eastern Finnish men","volume":"20","author":"Tuomainen","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacl.2018.06.017_bib8","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1186\/1471-2458-14-483","article-title":"Ferritin levels and risk of metabolic syndrome: meta-analysis of observational studies","volume":"14","author":"Abril-Ulloa","year":"2014","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jacl.2018.06.017_bib9","first-page":"13317","article-title":"Association between serum ferritin levels and metabolic syndrome: an updated meta-analysis","volume":"8","author":"Jin","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.jacl.2018.06.017_bib10","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.2337\/dc12-0543","article-title":"Association of serum ferritin and the development of metabolic syndrome in middle-aged Korean men: a 5-year follow-up study","volume":"35","author":"Park","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacl.2018.06.017_bib11","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.2337\/dc06-2312","article-title":"Ferritin and transferrin are associated with metabolic syndrome abnormalities and their change over time in a general population: Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR)","volume":"30","author":"Vari","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacl.2018.06.017_bib12","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.metabol.2009.06.021","article-title":"Serum ferritin is a major determinant of lipid phenotype in familial combined hyperlipidemia and familial hypertriglyceridemia","volume":"59","author":"Mateo-Gallego","year":"2010","journal-title":"Metabolism"},{"key":"10.1016\/j.jacl.2018.06.017_bib13","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1210\/jc.2009-0814","article-title":"Mutations in HFE causing hemochromatosis are associated with primary hypertriglyceridemia","volume":"94","author":"Solanas-Barca","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacl.2018.06.017_bib14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2337\/dc07-0939","article-title":"Bloodletting ameliorates insulin sensitivity and secretion in parallel to reducing liver iron in carriers of HFE gene mutations","volume":"31","author":"Equitani","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacl.2018.06.017_bib15","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.metabol.2010.07.035","article-title":"Effect of phlebotomy on lipid metabolism in subjects with hereditary hemochromatosis","volume":"60","author":"Casanova-Esteban","year":"2011","journal-title":"Metabolism"},{"key":"10.1016\/j.jacl.2018.06.017_bib16","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.tcb.2017.01.006","article-title":"Inflammation and the metabolic syndrome: the tissue-specific functions of NF-\u03baB","volume":"27","author":"Catrysse","year":"2017","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.jacl.2018.06.017_bib17","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00011-009-0060-4","article-title":"The major inflammatory mediator interleukin-6 and obesity","volume":"58","author":"Eder","year":"2009","journal-title":"Inflamm Res"},{"key":"10.1016\/j.jacl.2018.06.017_bib18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s12185-017-2365-3","article-title":"The mechanisms of systemic iron homeostasis and etiology, diagnosis, and treatment of hereditary hemochromatosis","volume":"107","author":"Kawabata","year":"2018","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jacl.2018.06.017_bib19","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1093\/ajcn\/87.5.1374","article-title":"Pathways underlying iron accumulation in human nonalcoholic fatty liver disease","volume":"87","author":"Aigner","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jacl.2018.06.017_bib20","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1056\/NEJMoa041534","article-title":"Hemochromatosis and Iron Overload Screening (HEIRS) Study Research Investigators. Hemochromatosis and iron-overload screening in a racially diverse population","volume":"352","author":"Adams","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2018.06.017_bib21","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jacl.2015.02.003","article-title":"National lipid association recommendations for patient-centered management of dyslipidemia: part 1\u2014full report","volume":"9","author":"Jacobson","year":"2015","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2018.06.017_bib22","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.3945\/jn.114.191775","article-title":"Serum lipid responses to weight loss differ between overweight adults with familial hypercholesterolemia and those with familial combined hyperlipidemia","volume":"144","author":"Mateo-Gallego","year":"2014","journal-title":"J Nutr"},{"key":"10.1016\/j.jacl.2018.06.017_bib23","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.jacl.2018.06.017_bib24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.atherosclerosis.2011.06.028","volume":"217","author":"Catapano","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2018.06.017_bib25","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1056\/NEJMcp070061","article-title":"Clinical practice. Hypertriglyceridemia","volume":"357","author":"Brunzell","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2018.06.017_bib26","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S2213-8587(14)70032-4","article-title":"Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome","volume":"2","author":"Yki-J\u00e4rvinen","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jacl.2018.06.017_bib27","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2018.06.017_bib28","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1002\/hep.27662","article-title":"The impact of phlebotomy in nonalcoholic fatty liver disease: A prospective, randomized, controlled trial","volume":"61","author":"Adams","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jacl.2018.06.017_bib29","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.2337\/diabetes.51.4.1000","article-title":"Blood letting in high-ferritin type 2 diabetes: effects on insulin sensitivity and beta-cell function","volume":"51","author":"Fernandez-Real","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.jacl.2018.06.017_bib30","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nri3863","article-title":"Iron homeostasis in host defense and inflammation","volume":"15","author":"Ganz","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jacl.2018.06.017_bib31","doi-asserted-by":"crossref","first-page":"18975","DOI":"10.1074\/jbc.R115.650150","article-title":"Regulation of iron metabolism by hepcidin under conditions of inflammation","volume":"290","author":"Schmidt","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jacl.2018.06.017_bib32","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jhep.2008.03.011","article-title":"Hepcidin and iron-related gene expression in subjects with Dysmetabolic Hepatic Iron Overload","volume":"49","author":"Barisani","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.jacl.2018.06.017_bib33","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.3324\/haematol.2012.070979","article-title":"NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II). Hepcidin level predicts hemoglobin concentration in individuals undergoing repeated phlebotomy","volume":"98","author":"Mast","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.jacl.2018.06.017_bib34","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1111\/j.1572-0241.2007.01192.x","article-title":"Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study","volume":"102","author":"Valenti","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jacl.2018.06.017_bib35","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1053\/gast.2002.32403","article-title":"Effect of iron depletion in carbohydrate-intolerant patients with clinical evidence of nonalcoholic fatty liver disease","volume":"122","author":"Facchini","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jacl.2018.06.017_bib36","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1055\/s-0029-1192044","article-title":"Adipose tissue dysfunction in obesity","volume":"117","author":"Bl\u00fcher","year":"2009","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.jacl.2018.06.017_bib37","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nri2921","article-title":"Adipokines in inflammation and metabolic disease","volume":"11","author":"Ouchi","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jacl.2018.06.017_bib38","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1530\/EJE-11-0431","article-title":"RBP4: a controversial adipokine","volume":"165","author":"Kotnik","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"Suppl 1","key":"10.1016\/j.jacl.2018.06.017_bib39","doi-asserted-by":"crossref","first-page":"383S","DOI":"10.3945\/ajcn.116.142307","article-title":"Adjusting total body iron for inflammation: Biomarkers Reflecting Inflammation and Nutritional Determinants of Anemia (BRINDA) project","volume":"106","author":"Mei","year":"2017","journal-title":"Am J Clin Nutr"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287418302757?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287418302757?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T19:02:22Z","timestamp":1720378942000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287418302757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S1933287418302757"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2018.06.017","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of repeated phlebotomies in hypertriglyceridemia and iron overload: A prospective, randomized, controlled trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2018.06.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 National Lipid Association. All rights reserved.","name":"copyright","label":"Copyright"}]}}